Jeffrey Trent

Q: What Schools Are Affiliated With Jeffrey Trent

Jeffrey Trent is affiliated with the following schools: Washington University in St. Louis, University of Arizona, University of Michigan, University of Basel, Lund University, University of Washington

Jeffrey Trent's AcademicInfluence.com Rankings

Jeffrey Trent

Biology

#2694

World Rank

#4250

Historical Rank

Genetics

#343

World Rank

#402

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jeffrey Trent Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jeffrey M. Trent is the founding president and director of the Translational Genomics Research Institute. He has been vice president and Research Director of the Van Andel Institute since 2009. He was the founding director of NIH's National Human Genome Research Institute in 1993.

(See a Problem?)

Jeffrey Trent's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

WAF1, a potential mediator of p53 tumor suppression (1993) (8623)
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer (1993) (2347)
Use of a cDNA microarray to analyse gene expression patterns in human cancer (1996) (2148)
Genomic Classification of Cutaneous Melanoma (2015) (2143)
The transcriptional program in the response of human fibroblasts to serum. (1999) (2092)
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. (1999) (1817)
Expression profiling using cDNA microarrays (1999) (1780)
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. (1997) (1725)
High frequency of BRAF mutations in nevi (2003) (1657)
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour (1983) (1404)
KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. (1996) (966)
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. (2002) (940)
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines (1985) (812)
Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search (1996) (801)
Identification of an amplified, highly expressed gene in a human glioma. (1987) (703)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome (2002) (658)
Microarrays and toxicology: The advent of toxicogenomics (1999) (638)
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. (1998) (632)
Evidence for a prostate cancer susceptibility locus on the X chromosome. (1998) (620)
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. (2001) (527)
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 (2002) (523)
APC binds to the novel protein EB1. (1995) (516)
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. (1993) (499)
α-methylacyl-CoA racemase: A new molecular marker for prostate cancer (2002) (480)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma (2011) (414)
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk (2002) (395)
The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* (2007) (355)
Comparative properties of five human ovarian adenocarcinoma cell lines. (1985) (347)
Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses (1999) (337)
Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. (1990) (334)
Direct cloning of human ovarian carcinoma cells in agar. (1978) (326)
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. (2005) (323)
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome (1999) (322)
Data management and analysis for gene expression arrays (1998) (320)
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes (2007) (315)
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc (1984) (311)
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. (1983) (306)
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia (2003) (287)
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (2014) (271)
Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation (2000) (267)
Rapid generation of region specific probes by chromosome microdissection and their application (1992) (261)
Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. (1991) (238)
Common sequence variants on 20q11.22 confer melanoma susceptibility (2008) (238)
Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays (1999) (236)
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma (1997) (234)
Transcription Program of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus) (2001) (234)
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. (2002) (231)
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. (1999) (230)
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. (2008) (227)
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. (2003) (218)
Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. (1999) (212)
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. (1998) (209)
A Nuclear Factor, ASC-2, as a Cancer-amplified Transcriptional Coactivator Essential for Ligand-dependent Transactivation by Nuclear Receptors in Vivo * (1999) (208)
Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities (2012) (205)
Molecular classification of familial non-BRCA1/BRCA2 breast cancer (2003) (204)
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. (1987) (203)
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer (2004) (201)
Ratio statistics of gene expression levels and applications to microarray data analysis (2002) (199)
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. (1996) (198)
Biological differences among MCF-7 human breast cancer cell lines from different laboratories (2005) (190)
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases (2002) (189)
Glioma Cell Motility is Associated with Reduced Transcription of Proapoptotic and Proliferation Genes: A cDNA Microarray Analysis (2001) (188)
Expression profiling in cancer using cDNA microarrays (1999) (186)
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. (1995) (184)
Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. (1982) (183)
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. (2002) (182)
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. (2003) (178)
Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12 (2008) (174)
Toward precision medicine in glioblastoma: the promise and the challenges. (2015) (173)
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene (1999) (171)
Molecular determinants of human uveal melanoma invasion and metastasis (2004) (171)
Inference from Clustering with Application to Gene-Expression Microarrays (2002) (166)
Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies (2001) (165)
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type (2015) (164)
Report of the committee on chromosome changes in neoplasia (1990) (160)
Telomere capture stabilizes chromosome breakage (1993) (157)
Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. (1988) (156)
Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. (1996) (156)
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. (2001) (155)
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection (1994) (155)
Induction of Gene Expression as a Monitor of Exposure to Ionizing Radiation (2001) (153)
Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. (1995) (153)
Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. (1989) (148)
Report of the committee on structural chromosome changes in neoplasia. (1988) (147)
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 (2011) (146)
Identification of combination gene sets for glioma classification. (2002) (143)
Generation of band-specific painting probes from a single microdissected chromosome. (1993) (141)
Differential responses of stress genes to low dose-rate gamma irradiation. (2003) (140)
Differential Responses of Stress Genes to Low Dose-Rate ; Irradiation (2003) (139)
Molecular cytogenetic analysis of i(12p)‐negative human male germ cell tumors (1993) (139)
Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. (2015) (138)
Stress-specific signatures: expression profiling of p53 wild-type and -null human cells (2005) (137)
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. (2004) (136)
Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization (2000) (135)
AIM1, a novel non-lens member of the βγ-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma (1997) (133)
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. (2011) (132)
Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis (2002) (132)
Development and characterization of a melphalan-resistant human multiple myeloma cell line. (1991) (131)
Report of the committee on chromosome changes in neoplasia. (1990) (128)
Nuclear architecture and the induction of chromosomal aberrations. (1996) (127)
Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. (1984) (127)
Report of the committee on structural chromosome changes in neoplasia. (1989) (124)
A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma (2012) (124)
Localization of a novel melanoma susceptibility locus to 1p22. (2003) (124)
Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. (1995) (124)
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma (2009) (123)
Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma (2014) (123)
A genome scan for eye color in 502 twin families: most variation is due to a QTL on chromosome 15q. (2004) (119)
Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants (1987) (117)
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. (1999) (116)
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus (1997) (116)
Gene-expression profiling in human cutaneous melanoma (2003) (116)
Chromosome arm painting probes (1996) (114)
Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization (2001) (114)
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. (2001) (114)
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. (1997) (113)
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer (2010) (113)
Advancing a clinically relevant perspective of the clonal nature of cancer (2011) (111)
Rapid generation of whole chromosome painting probes (WCPs) by chromosome microdissection. (1994) (110)
Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. (1992) (108)
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer (2009) (108)
Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture. (1981) (108)
Development of a prostate cDNA microarray and statistical gene expression analysis package (2000) (107)
Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. (1989) (106)
Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. (1979) (105)
MYB oncogene amplification in hereditary BRCA1 breast cancer. (2000) (104)
Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. (1991) (104)
Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology (2016) (103)
Localization of a gene for Duane retraction syndrome to chromosome 2q31. (1999) (102)
Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. (1996) (101)
Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. (1990) (101)
Genome‐wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1 (2003) (101)
Data analysis and integration: of steps and arrows (1999) (100)
Strong Feature Sets from Small Samples (2002) (99)
Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. (2001) (99)
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. (2000) (98)
Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. (2017) (97)
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. (1998) (96)
Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation (2001) (96)
The Interaction of Four Genes in the Inflammation Pathway Significantly Predicts Prostate Cancer Risk (2005) (95)
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. (2000) (95)
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. (2002) (94)
Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily. (1987) (94)
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. (2000) (92)
Clonal chromosome abnormalities in human breast carcinomas I. Twenty‐eight cases with primary disease (1993) (92)
Evaluation of pre-analytical factors affecting plasma DNA analysis (2017) (90)
Combined genome-wide scan for prostate cancer susceptibility genes. (2004) (89)
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk (2002) (88)
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma (2015) (86)
Linkage of prostate cancer susceptibility loci to chromosome 1 (2001) (86)
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer (2004) (86)
Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases (1999) (84)
Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. (1999) (83)
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib (2014) (82)
Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families (2003) (81)
SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. (1994) (79)
In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. (1999) (78)
Biological indicators for the identification of ionizing radiation exposure in humans (2001) (77)
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type. (2016) (77)
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome (2004) (76)
Functional evidence implicating S100P in prostate cancer progression (2008) (76)
Construction of a representative cDNA library from prostatic intraepithelial neoplasia. (1996) (75)
A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population. (2012) (74)
A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history (2005) (74)
A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions (2007) (74)
Clonal chromosome abnormalities in human breast carcinomas II. Thirty‐four cases with metastatic disease (1993) (74)
Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. (2005) (73)
A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters. (2016) (73)
Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing (2011) (73)
Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion (2014) (72)
Mapping of the gene encoding the melanocortin-1 (alpha-melanocyte stimulating hormone) receptor (MC1R) to human chromosome 16q24.3 by Fluorescence in situ hybridization. (1994) (71)
Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. (1988) (71)
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type (2017) (70)
Separate and variably shaped chromosome arm domains are disclosed by chromosome arm painting in human cell nuclei (1998) (70)
Adrenocortical carcinoma survival rates correlated to genomic copy number variants (2008) (69)
The genetics of cutaneous melanoma. (2000) (69)
Amplification units containing human N-myc and c-myc genes. (1986) (68)
A genome-wide association study reveals that variants within the HLA region are associated with risk for nonobstructive azoospermia. (2012) (68)
Differentially painting human chromosome arms with combined binary ratio-labeling fluorescence in situ hybridization. (2000) (68)
Identification of Tumor‐Suppressor Genes Using Human Melanoma Cell Lines UACC903, UACC903(+6), and SRS3 by Comparison of Expression Profiles (2000) (67)
Simulation of cDNA microarrays via a parameterized random signal model. (2002) (67)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors. (2020) (67)
Expression of the zinc finger gene EVI-1 in ovarian and other cancers. (1996) (67)
Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and "multidimensionally impaired". (1998) (65)
Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7. (1985) (64)
Rapid generation of region-specific genomic clones by chromosome microdissection: isolation of DNA from a region frequently deleted in malignant melanoma. (1992) (64)
Notch and NOXA-related pathways in melanoma cells. (2005) (64)
Methods for chromosome banding of human and experimental tumors in vitro. (1987) (62)
Genome‐wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25‐26 (2003) (61)
Localization of the human thyroxine-binding globulin gene to the long arm of the X chromosome (Xq21-22). (1987) (61)
Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men. (2012) (60)
Complete sequence analysis of a gene (OS‐9) ubiquitously expressed in human tissues and amplified in sarcomas (1996) (60)
Gene expression in inherited breast cancer. (2002) (59)
HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II. (1990) (58)
A novel missense mutation in ACTG1 causes dominant deafness in a Norwegian DFNA20/26 family, but ACTG1 mutations are not frequent among families with hereditary hearing impairment (2006) (58)
Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change. (1985) (58)
A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers (2013) (58)
Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma. (1996) (58)
AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. (1997) (57)
Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis (2000) (55)
Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer (2001) (55)
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. (1999) (54)
Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus. (2001) (54)
Cytogenetic analysis of posterior uveal melanoma. (1993) (54)
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma (2017) (53)
Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. (2000) (51)
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen (Cancer Research (January 15, 2008) 68 (415-424)) (2008) (51)
Genome‐wide screen for prostate cancer susceptibility genes in men with clinically significant disease (2005) (51)
Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families (2001) (51)
Rapid isolation and characterization of amplified DNA by chromosome microdissection: identification of IGF1R amplification in malignant melanoma. (1993) (50)
Genome-Wide Association Study for Serum Complement C3 and C4 Levels in Healthy Chinese Subjects (2012) (50)
Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays (2003) (48)
A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF (2017) (48)
Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. (1996) (47)
Gain of 9p in the pathogenesis of polycythemia vera (1998) (47)
Stress-gene induction by low-dose gamma irradiation. (2002) (47)
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis (2018) (46)
Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. (2005) (46)
Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. (1995) (44)
Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma (1994) (44)
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (2018) (44)
Effects of HIV-1 Nef on cellular gene expression profiles. (2002) (43)
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition (2018) (43)
WAR , a Potential Mediator of ~ 53 Tumor Suppression (2003) (42)
Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance. (1987) (42)
Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9‐mb interval (2004) (42)
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) (2014) (41)
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines (2020) (41)
Direct isolation of genes encoded within a homogeneously staining region by chromosome microdissection. (1994) (40)
Cloning and characterization of a novel gene, SHPRH, encoding a conserved putative protein with SNF2/helicase and PHD-finger domains from the 6q24 region. (2003) (40)
Fine-mapping the putative chromosome 17q21–22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis (2007) (39)
Loss of Inositol Polyphosphate 5-Phosphatase Is an Early Event in Development of Cutaneous Squamous Cell Carcinoma (2010) (39)
Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma (1997) (39)
Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia (1993) (39)
A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region (2005) (39)
Chromosome arm‐specific multicolor FISH (2001) (39)
Genome-wide scanning for linkage in Finnish breast cancer families (2004) (37)
Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials (2014) (37)
Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. (1997) (37)
Conditioning-Based Modeling of Contextual Genomic Regulation (2009) (37)
Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma. (1996) (36)
Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis. (1985) (36)
Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. (2000) (36)
Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2 (2019) (36)
Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples (2009) (36)
Human tumour karyology: marked analytic improvement by short-term agar culture. (1980) (35)
High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells (2011) (35)
Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population (2010) (34)
Noise factor analysis for cDNA microarrays. (2004) (34)
Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations. (1987) (34)
The establishment and morphologic characterization of finite cell lines from normal human endometrium. (1980) (34)
Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer (2000) (33)
Expression of silver-stained nucleolar organizing regions (Ag-NORs) in human cancer. (1981) (33)
The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies. (1995) (33)
A cell line from a human ovarian carcinoma with amplification of the K-ras gene. (1986) (33)
Which is better for cDNA-microarray-based classification: ratios or direct intensities (2004) (32)
Tumor progression studied by analysis of cellular features of serial ascitic ovarian carcinoma tumors. (1983) (32)
Isolation of genes amplified in human cancers by microdissection mediated cDNA capture. (1996) (32)
Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus (2004) (32)
African-American heredity prostate cancer study: a model for genetic research. (2001) (32)
Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage (2003) (31)
Chromosome abnormalities in ovarian adenocarcinoma: II. prognostic impact of nonrandom chromosome abnormalities in 244 cases (1999) (30)
Tracking transcriptional activities with high-content epifluorescent imaging. (2012) (30)
Genome-wide homozygosity mapping localizes a gene for autosomal recessive non-progressive infantile ataxia to 20q11-q13 (2003) (30)
Identification and characterization of mouse Rab32 by mRNA and protein expression analysis. (2003) (29)
A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. (2000) (29)
The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma (2000) (28)
Maternal balanced translocation leading to partial duplication of 4q and partial deletion of 1p in a son: cytogenetic and FISH studies using band-specific painting probes generated by chromosome microdissection. (1997) (28)
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer (2020) (27)
The last shall be first (1993) (27)
Evidence for selection of homogeneously staining regions in a human melanoma cell line. (1984) (27)
Molecular cloning of human hic‐5, a potential regulator involved in signal transduction and cellular senescence (2000) (26)
Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line. (1988) (26)
17 – Cytogenetic and Molecular Biologic Alterations Associated with Anthracycline Resistance (1988) (26)
Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. (2001) (26)
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis (2020) (25)
Evidence of allelic imbalance of chromosome 6 in human astrocytomas. (1994) (25)
Molecular mapping of the oncogene MYB and rearrangements in malignant melanoma (1989) (24)
Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene. (1988) (24)
Chromosomal localization of four human VH1-like protein-tyrosine phosphatases. (1994) (24)
Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma. (1997) (24)
Identification of a prostate cancer susceptibility locus on chromosome 7q11–21 in Jewish families (2004) (24)
Direct evidence for homologous sequences on the paracentric regions of human chromosome 1. (1994) (24)
Mapping of the immune interferon gamma gene (IFNG) to chromosome band 12q14 by fluorescence in situ hybridization. (1995) (23)
Genome‐wide linkage of 77 families from the African American Hereditary Prostate Cancer Study (AAHPC) (2007) (23)
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. (2003) (23)
Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC study (2004) (23)
Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12 (2006) (23)
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma (2015) (23)
Integration of genomic technologies for accelerated cancer drug development. (2003) (22)
Identification and mapping of type 1 neurofibromatosis (NF1) homologous loci. (1996) (22)
Gene amplification in cancer: a molecular cytogenetic approach. (1986) (22)
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non–V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team (2015) (22)
Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation. (1984) (21)
Abstracts for the committee on the genetic constitution of chromosome 1 (1991) (21)
8q24 risk alleles and prostate cancer in African‐Barbadian men (2014) (21)
Quick method for high yields of λ bacteriophage DNA (1990) (21)
Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia. (1983) (20)
Abstracts of workshop presentations (Part 2 of 16) (1987) (20)
Physical and transcript map of the hereditary prostate cancer region at xq27. (2002) (20)
Evidence of allelic imbalance of chromosome 6 in human astrocytomas (1993) (20)
Identification of a ring chromosome in a myxoid malignant fibrous histiocytoma with chromosome microdissection and fluorescence in situ hybridization. (1999) (19)
Abstracts of workshop presentations (Part 6 of 16) (1987) (19)
Development and utilization of a somatic cell hybrid mapping panel to assign NotI linking probes to the long arm of human chromosome 6. (1992) (19)
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases (2018) (19)
Role of genomics in identifying new targets for cancer therapy. (2002) (19)
Report of the committee on structural chromosome changes in neoplasia. (1987) (19)
Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. (1996) (19)
Efficient selection of feature sets possessing high coefficients of determination based on incremental determinations (2003) (18)
Isolation of a cosmid sublibrary for a region of chromosome 12 frequently amplified in human cancers using a complex chromosome microdissection probe. (1996) (18)
Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2 (2019) (18)
Cloning and tissue expression of the mouse ortholog of AIM1, a βγ-crystallin superfamily member (1998) (18)
Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma. (1999) (17)
Detection of chromosome 6 abnormalities in melanoma cell lines by chromosome arm painting probes. (1998) (17)
Characterization of X Chromosome Inactivation Using Integrated Analysis of Whole-Exome and mRNA Sequencing (2014) (17)
Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma (2019) (17)
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma (2020) (17)
Human PCK1 encoding phosphoenolpyruvate carboxykinase is located on chromosome 20q13.2. (1993) (17)
Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection. (2002) (16)
Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability (2012) (16)
Cytogenetic and molecular biologic alterations in human breast cancer: A review (2005) (16)
DNA amplification associated with double minutes originating from chromosome 19 in mouse hepatocellular carcinoma (2001) (16)
Microdissection based cloning of a translocation breakpoint in a human malignant melanoma. (1995) (16)
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (2008) (15)
Gene amplification elucidated by combined chromosomal microdissection and comparative genomic hybridization. (1995) (15)
Cytogenetic and clinical assessment of six patients with erythroleukemia. (1983) (15)
Clinical implications of cytogenetic abnormalities in melanoma. (1996) (15)
The value of molecular haplotypes in a family-based linkage study. (2006) (15)
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect (2006) (15)
Report of the First International Workshop on Human Chromosome 6 Mapping 1992 (1993) (15)
The BioIntelligence Framework: a new computational platform for biomedical knowledge computing (2013) (14)
Association of prostate cancer risk with snps in regions containing androgen receptor binding sites captured by ChIP‐On‐chip analyses (2012) (14)
An Integrated Framework for Reporting Clinically Relevant Biomarkers from Paired Tumor/Normal Genomic and Transcriptomic Sequencing Data In Support of Clinical Trials in Personalized Medicine (2014) (14)
Regional assignment by hybrid mapping of 36 expressed sequence tags (ESTs) on human chromosome 6. (1995) (14)
Mapping of the gene encoding the alpha-subunit of the human H+,K(+)-ATPase to chromosome 19q13.1 by fluorescent in situ hybridization. (1992) (14)
Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates. (1986) (13)
Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms. (1991) (13)
DYNAMICAL ANALYSIS OF DRUG EFFICACY AND MECHANISM OF ACTION USING GFP REPORTERS (2012) (13)
Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics (2008) (13)
Coverage of chromosome 6 by chromosome microdissection: generation of 14 subregion-specific probes (1995) (13)
Precision medicine: an opportunity for a paradigm shift in veterinary medicine. (2016) (13)
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines. (2020) (12)
Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. (1994) (12)
Isolation of chromosome-specific ESTs by microdissection-mediated cDNA capture. (1997) (12)
Prevalence and clinical significance of cytogenetic abnormalities in human ovarian cancer (1985) (12)
The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization. (2000) (12)
Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridization. (1994) (12)
Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene (2014) (12)
Performance characteristics of 65-mer oligonucleotide microarrays. (2007) (11)
HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases (2020) (11)
Improved methods for RNAseq-based alternative splicing analysis (2021) (11)
First results of a randomized phase IB study comparing nivolumab/ipilimumab with or without CBM-588 in patients with metastatic renal cell carcinoma. (2021) (11)
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type (2020) (11)
Nonlinear filters in genomic control (1999) (11)
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma (2017) (11)
Clustering analysis for gene expression data (1999) (11)
Analysis of Expression Patterns: The Scope of the Problem, the Problem of Scope (2002) (11)
Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus (1990) (10)
A unique malignant T‐cell lymphoproliferative disorder with neutropenia simulating hairy cell leukemia (1985) (10)
SDHD Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma. (2017) (10)
Identification of region specific genes by chromosome microdissection. (1997) (10)
Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. (1993) (10)
Chipping away at genomic medicine (2002) (10)
Cytogenetics of human malignant melanoma (1991) (10)
Chromosome Localization of P-Glycoprotein Genes in Drug-Sensitive and -Resistant Human Cells (1991) (10)
Abstracts of workshop presentations (Part 12 of 16) (1987) (10)
D-GROUP CHROMOSOME ABNORMALITIES IN ENDOMETRIAL CANCER AND HYPERPLASIA (1979) (10)
The use of restriction fragment polymorphisms to identify the cell line MCF-7 (2005) (10)
Cytogenetic analysis of human tumor cells cloned in agar. (1980) (10)
Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility (2019) (10)
GeneLink: a database to facilitate genetic studies of complex traits (2004) (10)
Cloning and tissue expression of the mouse ortholog of AIM1, a betagamma-crystallin superfamily member. (1998) (9)
Analysis of dihydrofolate reductase gene amplification in a methotrexate-resistant human tumor cell line. (1985) (9)
Molecular/cytogenetic alterations accompanying the development of multidrug resistance in the J774.2 murine cell line. (1988) (9)
Analysis of variability in high throughput screening data: applications to melanoma cell lines and drug responses (2017) (9)
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression (2020) (9)
Abstracts for the committee on comparative gene mapping (1991) (9)
Mapping of the gene encoding the beta-subunit of H+,K(+)-ATPase to human chromosome 13q34 by fluorescence in situ hybridization. (1992) (9)
A BAP 1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers (2013) (9)
Genetic and physical map of 11 short tandem repeat polymorphisms on human chromosome 6. (1993) (9)
What should oncologists know about cytogenetics in solid tumors? (1993) (8)
Isolation of YAC insert sequences by representational difference analysis. (1995) (8)
The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma (2015) (8)
Abstracts of workshop presentations (Part 15 of 16) (1987) (8)
Potential applications of a human tumor stem cell bioassay to the cytogenetic assessment of human cancer (1980) (8)
Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells. (1994) (8)
Protocols of procedures and techniques in chromosome analysis of tumor stem cell cultures in soft agar. (1980) (8)
Optimization of oligonucleotide microarray fabricated by spotting 65-mer. (2007) (8)
Genome-wide scanning for linkage in Finnish breast cancer families (2004) (7)
Alu-PCR: characterization of a chromosome 6-specific hybrid mapping panel and cloning of chromosome-specific markers. (1992) (7)
Abstracts of workshop presentations (Part 10 of 16) (1987) (7)
Assignment of interferon gamma receptor (IFNGR1) to human chromosome bands 6q24.1-->q24.2 by in situ hybridization. (1997) (7)
Molecular probes in neuro-oncology: a review. (1990) (7)
Large-scale physical mapping within the region 22q12.3-13.1 in meningioma. (1991) (7)
Cytogenetics and clinical correlations in breast cancer. (1993) (7)
Analysis of fragment ends in plasma DNA from patients with cancer (2021) (7)
Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis (1991) (6)
Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. (2020) (6)
Abstracts of workshop presentations pp. 1040-1056 (1989) (6)
Evidence for linear extrachromosomal elements mediating gene amplification in the multidrug-resistant J774.2 murine cell line. (1992) (6)
Advances in Brief Human Prostate Cancer and Benign Prostatic Hyperplasia : Molecular Dissection by Gene Expression Profiling 1 (2001) (6)
Chromosome breakpoint at 17q11.2 and insertion of DNA from three different chromosomes in a glioblastoma with exceptional glial fibrillary acidic protein expression. (1996) (6)
Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients (2018) (6)
A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research. (2022) (6)
Advances in Brief The Association of Chromosome 8 p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma 1 (1999) (6)
Cloning and characterization of an inversion breakpoint at 6q23.3 suggests a role for Map7 in sacral dysgenesis (2004) (6)
Possible relationship between chromosome alterations and in vitro cellular radiosensitivity of human malignant melanoma. (1990) (6)
Molecular profiling using immunohistochemistry (IHC) and DNA microarray (DMA) as a tool to determine potential therapeutic targets in patients who have progressed on multiple prior therapies (2006) (5)
31 Recurring sites of chromosome change in human ovarian carcinoma (1987) (5)
Abstracts of workshop presentations pp. 1023-1039 (1989) (5)
Clinical correlations of chromosome change in human solid tumors: the tip of the iceberg? (1989) (5)
Abstracts of workshop presentations pp. 948-967 (1989) (5)
American College of Rheumatology Basic Research Conference: Genetics and genomics in rheumatic disease. (2002) (5)
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion (2021) (5)
The Gene Topography of Cancer (2007) (5)
Abstracts for the committee on the genetic constitution of the X chromosome (Part 3 of 3) (1991) (5)
Summary perspectives: First international workshop on chromosomes in solid tumors (1986) (5)
Obtaining and Evaluating Gene Expression Profiles with cDNA Microarrays (2002) (5)
Abstracts for the committee on the genetic constitution of chromosome 17 (1991) (5)
Assessing Combinational Drug Efficacy in Cancer Cells by Using Image-based Dynamic Response Analysis (2015) (4)
Evidence for rearrangement and amplification of the c-myc cellular oncogene in a human glioblastoma (1985) (4)
Abstracts of workshop presentations (Part 3 of 16) (1987) (4)
Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition (2017) (4)
Analysis of the Length of S‐Phase Required to Show Sister Chromatid Differential Staining (1986) (4)
Abstracts of workshop presentations (Part 1 of 16) (1987) (4)
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients (2020) (4)
Abstracts for the committee on the genetic constitution of chromosome 2 (1991) (4)
Loss of tumorigenicity in a methotrexate-resistant human leukemia cell line. (1993) (4)
Abstracts of workshop presentations pp. 1057-1074 (1989) (4)
Abstracts of workshop presentations (Part 7 of 16) (1987) (4)
Summary of Human Gene Map, New Haven, HGM – 1, 1973, ‘Data 1' (1989) (4)
Abstracts for the committee on the genetic constitution of chromosome 6 (1991) (4)
Stress gene expression: analysis by informatics and functional genomics approaches (1999) (4)
Genome-wide association study identifies novel loci associated with serum level of vitamin B 12 in Chinese men (2012) (4)
MR Neurographic Findings in Diagnosis of Thoracic Outlet Syndrome: 720 (1997) (4)
Identification of 3'-terminal exons from yeast artificial chromosomes. (1995) (4)
Cellular and genetic properties of two melanoma cell lines established from the same tumor. (1988) (3)
Microarray Image Analysis and Gene Expression Ratio Statistics (2006) (3)
Abstracts of workshop presentations pp. 1075-1091 (1989) (3)
Chromosome 1p terminal deletion and loss of chromosome 17p and 16p are common findings in nasal NK/T cell lymphoma by comparative genomic hybridization (1998) (3)
Generation and characterization of a human chromosome 6-specific hncDNA library from a somatic cell hybrid. (1995) (3)
Molecular pathophysiologic hints into Niemann-Pick Type C disease using cDNA microarray technology (1999) (3)
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial (2021) (3)
Abstracts for the committee on the genetic constitution of chromosome 12 (1991) (3)
16th European Colloqium on Animal Cytogenetics and Gene Mapping (2004) (3)
Increased frequency of P-glycoprotein gene amplification in colchicine-resistant Rat-1 clones transformed by v-src. (1997) (3)
Molecular cytogentetic analysis of an amplification unit on chromosome 12q (1993) (3)
Abstracts of workshop presentations (Part 8 of 16) (1987) (3)
35 The relationship of tumorigenicity to multidrug (MDR) resistance in human and experimental cancers (1987) (3)
Clinical correlations of chromosome abnormalities in human breast, melanoma and ovarian cancer: preliminary analyses of 580 patients (1995) (3)
Corrigendum: CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer (2004) (3)
Abstracts for the committee on chromosomal changes in neoplasia (1991) (3)
Abstracts of workshop presentations (Part 4 of 16) (1987) (3)
Quick method for high yields of lambda bacteriophage DNA. (1990) (3)
Abstracts for the committee on the genetic constitution of chromosome 15 (1991) (3)
Gene amplification affecting O(6)-alkylguanine-DNA alkyltransferase activity is not detected in nitrosourea resistant or sensitive human cell lines. (1990) (3)
Mining melanoma with microarrays (1999) (3)
Abstracts for the committee on the genetic constitution of chromosome 11 (1991) (2)
Microarray analysis discriminates BRCA2 mutation-positive from BRCA1 and sporadic breast cancer patient tumour biopsies (1999) (2)
Cytogenetic findings in 122 cases of breast carcinoma (1991) (2)
In vitro clonal assay for bladder cancer: The biologic potential of urothelium and determination of in vitro sensitivity to cytotoxic agents (1980) (2)
Abstracts of workshop presentations (Part 11 of 16) (1987) (2)
Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer. (2005) (2)
Strategies for testing intervention matching schemes in cancer. (2020) (2)
Abstracts of workshop presentations pp. 1106-1116 (1989) (2)
HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma. (2009) (2)
Time series inference from clustering (2001) (2)
Expression Analysis of Herpesvirus Transcription Programs Using cDNA Microarrays (1999) (2)
Elucidation of the Downstream Targets of the PAX3-FKHR Fusion Oncogene Found in Aveolar Rhabdomyosarcoma Using cDNA Microarrays (1999) (2)
Cancer. The gene topography of cancer. (2007) (2)
Possible relationship between chromosome alterations and radiosensitivity in human malignant melanoma (1989) (2)
Assessment of ESR1 and ERBB2 mutations in estrogen receptor positive (ER+) metastatic breast cancers (MBC). (2017) (2)
Identification of suppressor genes associated with the chromosome 6-mediated suppressed melanoma cell UACC903(+6) by cDNA microarray (1999) (2)
Abstracts of workshop presentations (Part 14 of 16) (1987) (2)
Cytogenetic abnormalities in 24 cases of stage II malignant melanoma (1993) (2)
Carcinoma Cell Line Resistant to Mitoxantrone Cytogenetic and Phenotypic Analysis of a Human Colon Updated (2006) (2)
Abstracts for the committee on the genetic constitution of chromosome 22 (1991) (2)
Advances in Brief MYB Oncogene Amplification in Hereditary BRCA 1 Breast Cancer 1 (2000) (2)
A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region (2005) (2)
Abstracts for the committee on the genetic constitution of chromosome 16 (1991) (2)
Abstracts of workshop presentations (Part 5 of 16) (1987) (2)
Studies of human metastatic melanoma colony-forming units (MCFU) in soft agar (1981) (2)
Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type (2019) (2)
Genomic and transcriptomic correlates of clinical benefit from immunotherapy and targeted therapy among patients with metastatic renal cell carcinoma (mRCC). (2020) (2)
Abstracts of the 32nd Annual American Cytogenetics Conference (1995) (2)
Abstract 4493: Germline findings in targeted tumor sequencing using matched normal DNA (2016) (2)
Loss of constitutional heterozygosity for loci on chromosome 6q in human malignant melanoma (1991) (1)
Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis (2017) (1)
DNA sequence amplification in malignant fibrous histiocytoma (1991) (1)
Radiomic features of renal cell carcinoma primary and metastatic sites as predictors of TERT and BAP1 mutations. (2021) (1)
Cytogenetic analysis of clonogenic human ovarian carcinoma cells exposed to cytostatic agents (1981) (1)
Contents Vol. 55, 1990 (1990) (1)
The Eighth International Workshop on Chromosomes in Solid Tumors. Tucson, Arizona, January 30- February 1, 2000. Abstracts. (1993) (1)
Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability (2012) (1)
Utilization of chromosome microdissection for rapid characterization of amplification-units in human cancer: Identification of igf-1R amplification in malignant melanoma. (1993) (1)
GENETIC EPIDEMIOLOGY OF HEREDITARY PROSTATE CANCER IN FINLAND: DISCOVERY OF NOVEL SUSCEPTIBILITY LOCI (1999) (1)
Abstracts for the committee on the genetic constitution of chromosome 7 (2004) (1)
Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network (2023) (1)
Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis (2018) (1)
Feasibility and promise of circulating tumor DNA analysis in dogs with naturally-occurring sarcoma (2020) (1)
New features and policies (1981) (1)
Report of the First International Workshop on Human Chromosome 6 Mapping. Ann Arbor, Michigan, June 7-9, 1992. (1993) (1)
Abstracts of workshop presentations (Part 9 of 16) (1987) (1)
Cytogenetic and molecular analysis of human malignant melanoma: The search for a suppressor gene on chromosome 6. (1991) (1)
Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line: isolation of a candidate tumor suppressor gene interrupted by the breakpoint at 6q16 (2000) (1)
Evaluation of pre-analytical factors affecting plasma DNA analysis (2018) (1)
Abstracts for the committee on the genetic constitution of chromosome 9 (1991) (1)
Erratum: A major locus for hereditary prostate cancer in Finland: Localization by linkage disequilibrium of a haplotype in the HPCX region (Human Genetics (2005) vol. 117 (307-316) 10.1007/s00439-005-1305-z) (2005) (1)
Instructions for the preparation of gene mapping reports (1995) (1)
Identification of a major susceptibility locus for human prostate cancer (1997) (1)
Abstract 5381: Therapeutic potential of HDAC inhibitors in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) (2015) (1)
Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions (2022) (1)
Abstracts for the committee on the genetic constitution of chromosome 4 (1991) (1)
Chromosome specific c-DNA libraries: reduction of unspecific priming events by purification of heteronuclear RNA (1994) (1)
Physical analysis of part of band 6q21 harboring a putative tumor suppressor gene and a putative senescence gene. (1996) (1)
Restriction Mapping of Recombinant Cosmid Clones Using λ Terminase and Field Inversion Gel Electrophoresis (1997) (1)
Asymptomatic Employee Screening for SARS-CoV-2: Implementation of and Reactions to an Employer-Based Testing Program. (2020) (1)
Analysis of the mechanisms of drug resistance in cancer by cDNA microarray (1999) (1)
Microdissection and microcloning of chromosomal alterations in human breast cancer (1995) (1)
Probing the genetic complement of cancer: Possible roles for double minutes in malignancy (1980) (1)
Inherited Genetic Changes in Prostate Cancer (2008) (1)
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer (2023) (1)
Generation and molecular cytogenetic characterization of a radiation-reduction hybrid panel for human chromosome 6. (1995) (1)
Abstract 3422: The influence of genetic and clinical factors on the outcome following a diagnosis of small cell carcinoma of the ovary, hypercalcemic type (2016) (1)
Abstracts for the committee on the genetic constitution of chromosome 10 (1991) (1)
Abstracts for the committee on the genetic constitution of chromosome 13 (1991) (1)
Recent advances in cancer cytogenetics. (1981) (1)
A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma (2022) (1)
Abstracts for the committee on the genetic constitution of the Y chromosome (1991) (1)
Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (2008) (1)
Detailed cytogenetic analysis of malignant melanoma (1993) (1)
Assignment of the human CRABP-II gene to chromosome 1q21 by nonisotopic in situ hybridization (1992) (1)
Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma (2019) (1)
Rapid generation of region-specific probes by chromosome microdissection: Application to the identification of chromosomal rearrangements (1993) (1)
Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type (2020) (1)
Advances in Brief-Methylacyl-CoA Racemase : A New Molecular Marker for Prostate Cancer 1 (2002) (1)
Chromosome 6 q Involvement in Human Malignant Melanoma (2002) (1)
Abstract Poster session BChromosome alterations in 71 cases of malignant metastatic melanoma (1989) (1)
Abstracts of workshop presentations (Part 16 of 16) (1987) (1)
Toxicant identification and classiacation using cDNA microarray technology (1998) (0)
Expression ratio statistics and its applications to microarray data analysis (2000) (0)
An altered gene expression profile is associated with tumour vasculogenesis by human melanoma cells (1999) (0)
Cytogenetic characterization, frequency and distribution of rob t(1;29) in some Italian and Portuguese cattle breeds (2004) (0)
A functional genomics approach using high-throughput RNAi to identify genes as gemcitabine sensitizing targets in pancreatic cancer (2007) (0)
Bisbee: A proteomics validated analysis package for detecting differential splicing, identifying splice outliers, and predicting splice event protein effects (2020) (0)
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies. (2022) (0)
Abstract 2023: Whole exome and RNA sequencing reveals genetic alterations in DNA damage and homologous recombination pathways in triple negative breast cancer. (2013) (0)
G-banding and fish show loss of chromosome 10 is a frequent finding in metastatic melanoma (1995) (0)
The biological significance of genetic alterations in human malignant melanoma: 7 (1993) (0)
Isolation of chromosome 6-specific transcribed sequences from somatic cell hybrids (1992) (0)
Use of experimentally constructed haplotypes in gene mapping studies of hereditary cancers (2001) (0)
Subject index Vol. 46, 1987 (1987) (0)
Erratum: CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer (Nature Medicine (200) 10 (7-381)) (2004) (0)
Contents, Vol. 46, 1987/ Title Page / Table of Contents (1987) (0)
Characterization of a mitomycin C (MMC) resistant L-1210 cell line (1985) (0)
Abstract B64: Analysis of somatic copy number alterations among African American patients with multiple myeloma using array CGH (2010) (0)
4 Cytogenetic and molecular genetic alterations associated with the development of anthracycline resistance (1987) (0)
Abstract NTOC-084: THE PROMISE OF COMBINATIONAL TREATMENT OF HISTONE DEACETYLASE 6 INHIBITOR ACY-1215 AND PROTEASOME INHIBITOR BORTEZOMIB IN SCCOHT (2017) (0)
Random signal model for cDNA microarrays (2001) (0)
38th Biennial American Cytogenetics Conference (2004) (0)
A note on the use of HGML LIT literature file numbers (1989) (0)
Abstracts of workshop presentations pp. 1006-1022 (1989) (0)
Author response: Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism (2020) (0)
Abstract 57: Integrating transcriptome profiling andin silicopathway analysis toward reduction of therapeutic dimensionality in nasopharyngeal carcinoma (2011) (0)
An in vitro clonal assay for bladder cancer: studies of the biologic potential of the urothelium and determination of in vitro sensitivity to cytotoxic agents. (1982) (0)
New familial syndrome associated with t(7;10) diagnosed as a result of the cytogenetic study of a breast carcinoma (1991) (0)
Abstracts of the 33rd Annual American Cytogenetics Conference (1995) (0)
Identification of a ring chromosome in a myxoid MFH with chromosome microdissection and fish (1997) (0)
Randomized prospective trial assessing Bifidobacterium-containing probiotic supplementation in metastatic renal cell carcinoma (mRCC) patients receiving vascular endothelial growth factor-tyrosine kinase inhibitors (VEGF-TKIs). (2020) (0)
Polyclonal origin of a primary breast carcinoma demonstrated by serial cytogenetic studies of a patient with a history of osteosarcoma (1993) (0)
Abstract 2779: Assessing germline and somatic alterations in DNA repair pathway in cancer (2017) (0)
Classification of hereditary breast cancers based on gene expression (2001) (0)
Amplified cDNAs isolated from microdissected HSRs using preparative in situ hybridization (1995) (0)
LOSS-OF-FUNCTION FGFR 2 MUTATIONS IN MELANOMA (2012) (0)
Development and Characterization of a Melphalan-resistant Human Multiple Myeloma Cell Line 1 ' 2 (2006) (0)
Advances in Brief Independent Ampiffication and Frequent Co-Amplification of Three Nonsyntenic Regions on the Long Arm of Chromosome 20 in Human Breast Cancer ' (2006) (0)
Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type (2017) (0)
2 IntegratedCancerGenomicsDivision,TranslationalGenomicsResearchInstitute(TGen),Phoenix,Arizona 3 DepartmentofPreventiveMedicine,KeckSchoolofMedicine,UniversityofSouthernCalifornia, (2014) (0)
International workshop on chromosome 6. Final report, June 1, 1992--May 31, 1993 (1994) (0)
QS131. SPARC Expression and Abraxane Efficacy in The Treatment of Adrenocortical Cancer (2008) (0)
Abstract 1476: Serglycin in nasopharyngeal carcinoma: A metastasis regulator and prognostic indicator (2011) (0)
Nivolumab/ipilimumab with or without CBM588 in metastatic renal cell carcinoma: A randomized phase Ib study and the evolution of the functionality of microbial communities with treatment. (2022) (0)
Index by Abstract Number (1989) (0)
Mosaicism for Turner's syndrome (45,X/46,XX) diagnosed after cytogenetic study of an ovarian tumor (1991) (0)
A-ZIPs: potent dominant negatives that abolish the DNA binding of B-ZIP transcription factors in a leucine zipper-dependent manner (1999) (0)
Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma. (2007) (0)
Large proportions of hereditary breast cancers are due to mutations in the two breast cancer susceptibility genes (2002) (0)
Abstract 3776: Identification of gene regulatory networks mediating melanoma cell resistance to temozolomide (2014) (0)
Subject Index, Vol. 76, 1997 (1997) (0)
Cytogenetic and molecular correlates of gene amplification in human and experimental cancers (1989) (0)
Assaying disease-specific gene expression by CDNA micro-arrays (1997) (0)
cDNA Microarrays Gene Expression Profiling of Alveolar Rhabdomyosarcoma with (2006) (0)
Cancer Genomics and Evolution (2017) (0)
Long range restriction mapping of PDGFB and D22S16 within the meningioma chromosomal region (MGCR) (1989) (0)
Development and Characterization of a Melphalan-resistant Human Multiple Myeloma Cell Line1'2 (2006) (0)
The plasticity of human Melanoma cells. (2004) (0)
Differential gene expression in multiple sclerosis lesions identified using cDNA microarrays (1998) (0)
Automated analysis of multivariate nonlinear gene relations based on cDNA microarray expression data (2000) (0)
Abstracts for the committee on the genetic constitution of the X chromosome (Part 2 of 3) (2004) (0)
Molecular Cytogenetic Characterization of the Sequential Development of Multidrug Resistance in Two Panels of Colchicine-Resistant Cell Lines (2020) (0)
Localization oftheHumanThyroxine-bindin g Globulin GenetotheLongArmoftheX Chromosome(Xq21-22) (1987) (0)
Generation of region-specific library and painting probes on chromosome 6 by micro-dissection (1993) (0)
Determining the quantitative accuracy of cDNA microarrays (1999) (0)
Abstract 1312: Identifying the genomic correlates of clinical benefit (CB) from immunotherapies (IO) and vascular endothelial growth factor-tyrosine kinase inhibitors (VEGF-TKI) in metastatic renal cell carcinoma (mRCC) (2020) (0)
Dna sequence amplification in a colon carcinoma cell line resistant to mitoxantrone (1986) (0)
Analysis of genomic alterations in cancer cell by chromosome microdissection (1995) (0)
CYTOGENETICS OF HUMAN MELANOMA RECURRJNG SITES OF CHROMOSOME CHANGE IN MALIGNANT MELANOMA (2017) (0)
Abstract LB-267: Whole-genome and transcriptome interrogation of metastatic chemo-resistant triple negative breast cancer from African American patients (2011) (0)
12 Correlation of chromosome 7 alterations with expression of epidermal growth factor receptor (EGF) in human glial and pancreatic carcinomas (1987) (0)
Wnt5a regulates Mart1 expression via increases in IL-6 (2005) (0)
Abstracts for the committee on the genetic constitution of chromosome 19 (1991) (0)
N-MYC localization to chromosome 2p23-24 and to homogenously staining regions (HSRs) on 3 different chromosomes in human neuroblastomas (1984) (0)
Subject Index, Vol. 69, 1995 (2004) (0)
Selective amplification of chromosome 6 specific DNA sequences by Alu-based PCR (1991) (0)
Abstract CT073: Peds-plan, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis (2018) (0)
SHORT COMMUNICATION Chromosome 6q Involvement in Human Malignant Melanoma (2002) (0)
Cytogenetic and Molecular Characterization of Tumors in Nude Mice Derived from a Multidrug-resistant Human Leukemia Cell Line 1 (2006) (0)
Chromosome microdissection identifies amplified and overexpressed cDNAs in human ovarian carcinoma (1997) (0)
1p36 structural abnormalities and t(1;17) in ovarian carcinoma (1995) (0)
Abstract B25: SMARCA4/BRG1 and AP-1 co-regulate an epithelial-like signature in small-cell carcinoma of ovary, hypercalcemic type (SCCOHT) (2020) (0)
Applying cDNA microarray technology to gene therapy (1999) (0)
Abstract AP32: THE METHYLTRANSFERASE EZH2 IS A VULNERABLE TARGET IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT) (2017) (0)
Chromosome microdissection identifies DNA sequence amplification in human ovarian carcinoma (1995) (0)
Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT) (2018) (0)
Clustering algorithms: can anything be concluded? (2001) (0)
Derivation of clones close to the oncogene myb in human malignant melanoma (1991) (0)
RAPID COMMUNICATION Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation (2000) (0)
Cells in the Absence of P-Glycoprotein Overexpression Multidrug Resistance in Mitoxantrone-selected HL-60 Leukemia Updated (2006) (0)
effusions: evidence for sequential in vivo clonal change Establishment of two new myeloma cell lines from bilateral pleural (2008) (0)
Mapping of not1 linking clones to chromosome 6q: Application to malignant melanoma (1989) (0)
Cell Lines Mechanisms of Doxorubicin Resistance in Two Human Tumor Pharmacological and Biological Evidence for Differing Updated (2006) (0)
Abstract 4487: An INDEL variant confers melanoma risk through PARP1 expression regulation (2016) (0)
Clinical correlations of chromosome change in human primary breast cancer (1990) (0)
Analysis of the mechanisms of drug resistance in cancer by cDNA microarray (1999) (0)
Abstracts for the committee on the genetic constitution of chromosome 14 (1991) (0)
The effects of age on sister-chromatid-exchange (1976) (0)
The human of ECT2 (Epithelial Cell Transforming Gene 2) mapping on chromosome 3q26.1–3q26.2 IS amplified in ovarian cancer cells (1997) (0)
Abstract C039: Influence of patient ancestry on homologous recombination repair deficiency in cancer (2023) (0)
Isolation and regional assignment of chromosome 6 specific HNCDNA clones to analyze human malignant melanoma (1994) (0)
Abstracts for the committee on the genetic constitution of chromosome 5 (1991) (0)
Integrated whole-exome and transcriptome analysis of 250 treatment-refractory or relapsed (R/R) childhood solid tumors. (2021) (0)
Expression of select-endothelial-specific genes by aggressive human melanoma cells Putative role of VE-cadherin in vasculogenic mimicry (2001) (0)
14 Renaturation gel analysis of amplified DNA sequences (1987) (0)
Abstract B01: Sustained clinical response to treatment directed by genomic expression profiling suggests mTOR signaling is an effective target in choroid plexus carcinoma (2015) (0)
Seventh international workshop on chromosomes in solid tumors: Tucson, Arizona January 20–22, 1997 (1997) (0)
Intestinal microbiome associated with development of grade 3/4 adverse in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (N/I) and probiotic support: Results from a phase Ib study. (2022) (0)
Molecular cloning and expression analysis of human and mouse homologs of a new transcriptional regulator as a candidate tumor suppresor gene (2001) (0)
63 Prospective Molecular Profiling of Canine Cancers Provides a Comparative Model for Evaluating Personalized Medicine Clinical Trials (2012) (0)
Abstract B47: Genomic screen of colorectal tumors and adenomas: Disproportionate frequency of 1p35-1pter deletion in synchronous advanced adenomas (2008) (0)
Mierodisseetion and mieroeloning of chromosomal breast cancer alterations in human (1995) (0)
A new class of thienopyrimidine Src inhibitors demonstrates potent growth suppression of imatinib resistant Ba/F3 cells harboring a wide range of BCR-ABL mutations, including the CML relevant T315I (2007) (0)
Abstract 6681: Inhibition of LSD1 using the reversible inhibitor SP2577 promotes Interferon dependent anti-tumor response in adrenocortical carcinoma (2020) (0)
Molecular profiling of prostate cancer progression (2001) (0)
Prospective genomic testing of unselected cancer patients yields insights about cancer susceptibility and noncancer disease with therapeutic implications. (2021) (0)
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. (2002) (0)
Abstracts for the comparative subcommittee on human and mouse homologies (1991) (0)
Abstracts for the committee on the mitochondrial genome (1991) (0)
Chromosome Microdissection for Detection of Subchromosomal Alterations by FISH. (2001) (0)
Customized Cancer Treatment: A Systems Biology Approach to Drug Selection (2011) (0)
Horizon November 14 2002 (2002) (0)
Arginine depletion through ADI-PEG20 to treat argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type (2019) (0)
Application of chromosome microdissection to the identification of complex chromosomal rearrangements in malignancy (1993) (0)
Detailed description of abnormal cytogenetic findings in 32 patients with metastatic melanoma (1991) (0)
The ‘stress chip’: a specialized functional genomics application for the study of genotoxic stress response (1999) (0)
Direct isolation of amplified cDNAs from 20q in breast cancer by chromosome microdissection (1995) (0)
Abstracts of workshop presentations (Part 13 of 16) (1987) (0)
Abstracts for the committee on linkage and gene order (1991) (0)
Abstracts for the committee on the genetic constitution of chromosome 20 (1991) (0)
Abstractsfor the informatics committee (1991) (0)
A study of the genetic progression of human cutaneous malignant melanoma by comparative genomic hybridization (1997) (0)
First assessment of the stool mycobiome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving targeted therapy (TT) or immunotherapy (IO). (2021) (0)
Cytogenetic comparison of multiple lesions from three patients with metastatic malignant melanoma (1989) (0)
Effects of HIV-1 Nef on Cellular Gene Expression Profiles (2002) (0)
Isolation d'un materiau sous visualisation microscopique (1996) (0)
From Chemistry to the Clinic: Pathways for Drug Discovery and Development. Part 2: Lead Generation, (2006) (0)
THE CYTOGENETIC AND FUNCTIONAL ASSESSMENT OF NORMAL, HYPERPLASTIC, AND CARCINOMATOUS ENDOMETRIUM IN VITRO (1979) (0)
Use of experimentally constructed haplotypes in gene mapping studies of hereditary cancers (2001) (0)
Subject Index Vol. 58, 1991 (1991) (0)
Abstract LB-058: GB-3103, an epigenetic immunomodulator, shows potent antitumor activity against tumors harboring dual loss of SMARCA4/SMARCA2 ATPases (2019) (0)
Use of cDNA Microarrays to Assess DNA Gene Expression Patterns in Cancer (1998) (0)
Abstracts for the committee on the genetic constitution of chromosome 18 (1991) (0)
Cancer evention esearch arch Article s of Inositol Polyphosphate 5-Phosphatase Is an Early nt in Development of Cutaneous Squamous Pr R l Carcinoma (2010) (0)
Abstract 3705: Identification of frequent HER2 activating mutations in canine primary pulmonary adenocarcinoma (2019) (0)
Wnt5a regulates melanoma antigen recognized by T-cells-1 (MART-1), a predominant antigen in melanoma cells. (2006) (0)
Identification by fish of non-uniform chromosome breakage in cancer cells treated with radiation ± BrdUrd (1993) (0)
Chromosome instability in 75 untreated ovarian cancer patients (1997) (0)
Evidence for specific, simple numeric abnormalities as primary karyotypic changes in ovarian carcinoma☆ (1993) (0)
Studies on the mechanism of extrachromosomal gene amplification in tumors (1992) (0)
Index by Keyword (1989) (0)
Third International Workshop on Chromosomes in Solid Tumors: February 26–28, 1989 Tucson, Arizona (1988) (0)
Once per cycle combination of long-acting hematopoietic growth factors (HGFs) pegfilgrastim and darbepoetin alfa (Peg-G + DPO) to reduce multi-lineage hematopoietic toxicity of chemotherapy with doxorubicin and ifosfamide (AI) in patients with sarcoma (2005) (0)
C6-04: Genomic profiling of tumour recurrence in non-small cell lung carcinoma (2007) (0)
African-American heredity prostate cancer study: a model for genetic research. (2001) (0)
An integrated approach to the extraction, storage, processing and analysis of microarray gene expression data (2001) (0)
DNA deletion mapping in meningioma by pulsed field gel electrophoresis (1989) (0)
Book reviews cell growth and apoptosis (1996) (0)
Clinical cytogenetic correlations in solid tumors (1997) (0)
Human tumor cloning : proceedings of the Fourth Conference on Human Tumor Cloning : Tucson, Arizona, January 8-10, 1984 (1984) (0)
Microdissecting the molecular stages of cancer progression, invasion and metastasis (1997) (0)
Abstract 4822: Analysis of somatic copy number alterations associated with poor prognosis and progression of multiple myeloma in African Americans (2010) (0)
Flow-cytometric isolation of neoplastic clones in clinical carcinomas coupled with aCGH enables profiling of novel and previously undetectable genomic aberrations. (2007) (0)
Location of met locus on chromosome 7 - A correction (Reply) (1990) (0)
P2.14-10 Identification of Frequent, Activating HER2 Mutations and HER2 Inhibitor Response and Resistance in Canine Lung Cancer (2019) (0)
Possible involvement of chromosome 7 in human squamous cell carcinoma (1987) (0)
Erratum: Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families (European Journal of Human Genetics (2008) 10.38/ejhg.2008.72) (2008) (0)
8 Chromosome microdissection of a region of chromosome 6 frequently deleted in malignant melanoma (1992) (0)
Stabilization of chromosome breakage by telomere capture: Demonstration by chromosome microdissection (1993) (0)
Index of GDB source ID numbers (1991) (0)
Identification of a consistent breakpoint at chromosome 6q11 in human follicular lymphoma by chromosome microdissection (1995) (0)
High definition clonal analysis of clinical vulnerabilities in carcinoma genomes (2008) (0)
Finding robust linear expression-based classifiers (2001) (0)
Abstract LB-160: A feasibility trial using molecular-guided therapy for the treatment of patients with refractory or recurrent neuroblastoma. (2013) (0)
Abstract 2013: Integrated proteomic analysis identifies four distinct subtypes of high-risk neuroblastoma (2022) (0)
Abstract 3151: High-throughput RNAi screening identifies a novel metastatic melanoma drug target in the context of PTEN mutation. (2013) (0)
Molecular dissection of human prostate cancer by gene expression analysis (2002) (0)
Abstractsfor the DNA committee (1991) (0)
Nonlinear stochastic determination for gene expressions via cDNA microarrays (1999) (0)
Floyd H. Thompson (1951–1996): In memoriam (1996) (0)
THE TRANSCRIPTION PROGRAM OF THE KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS HHV8 (1998) (0)
Restriction mapping of recombinant cosmid clones using lambda terminase and field inversion gel electrophoresis. (1997) (0)
The Multiple Myeloma Research Consortium Genomics Initiative. (2007) (0)
Abstract 3417: The genomic landscape of canine melanoma reveals broad mutational heterogeneity and recurrent patterns of structural variation (2014) (0)
Subject Index, Vol. 73, 1996 (1996) (0)
Defining genetic changes associated with cutaneous malignant melanoma (2001) (0)
Abstract LB-213: Discovery and molecular modeling of a novel mutation in the vemurafenib binding site of BRAF associated with therapeutic resistance in a patient with metastatic melanoma (2014) (0)
Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease (2008) (0)
Abstract 3389: Integrated genomic analyses reveal frequentTERTaberrations in acral melanoma (2017) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
Abstract A006: Increased germline mutational burden in individuals of African ancestry: Implications for interpretation of tumor mutation burden (2023) (0)
Identification of causal smoking-related DNA aberrations in lung cancers from current and former smokers: A6-07 (2007) (0)
Novel region of interest in chromosome 11 and other putative regions identified in a genome-wide scan in finnish hereditary prostate cancer families (2002) (0)
Cytogenetic analysis of 9 new human melanoma cell lines: Further evidence for involvement of chromosome 6 alterations (1987) (0)
A Genome Scan for Eye Color in 502 Twin Families: Most Variation is due to a QTL on Chromosome 15q (2004) (0)
Sample selection strategy using microarray-based CGH to identify a recurrent gene dosage alteration common to colorectal carcinomas and adenomas. (2006) (0)
Subject Index, Vol. 71 1995 (1995) (0)
Assignment of Alu-repetitive sequences to large restriction fragments from human chromosomes 6 and 22 (2004) (0)
Guidelines for interpreting abbreviations and specialized phrases in committee text and tables (1989) (0)
Abstract 4984: Association ofPTENandp16mutational status withMITFexpression may provide a novel context for a phenotype switch in melanoma (2011) (0)
Oncogenomics 2005 meeting report: dissecting cancer through genome research. (2005) (0)
Abstract 2204: A functional genomics approach using high-throughput RNAi identifies TNK1 as a putative oncogene in pancreatic cancer (2010) (0)
Genomic analysis to identify mediators of temozolomide sensitivity in metastatic melanoma (2007) (0)
Abstracts dscribing resources, technological and other developments (1991) (0)
Measurement of generation time (GT) and sister chromatid exchange (SCE) in human leukemic colony forming cells (LCFUs) (1982) (0)
LOSS-OF-FUNCTION FGFR2 MUTATIONS IN MELANOMA (2017) (0)
Abstract NTOC-090: TARGETING AND EFFICACY OF THE RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE, WORKS THROUGH INHIBITION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) (2017) (0)
Abstract LB-202: The rare, highly malignant small cell carcinoma of the ovary displays common inactivating germline and somatic mutations in the tumor suppressor SMARCA4 (2014) (0)
Corrigendum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (2014) (0)
Insulation cellular material under a microscope viewing. (1996) (0)
Abstract 494: Stemness characteristics contribute to metastasis and shorter patient survival in nasopharyngeal carcinoma (2011) (0)
Abstracts for the committee on the genetic constitution of chromosome 8 (1991) (0)
Fifth Intenational Workshop on Chromosomes in Solid Tumors (1993) (0)
Structural alterations of chromosome 19 in ovarian cancer: G-band and fish studies (1995) (0)
Abstracts for the committee on the genetic constitution of chromosome 21 (1991) (0)
Abstracts for the committee on clinical disorders and chromosomal deletion syndromes (1991) (0)
Relationship between gene expression profile and clinical outcome in malignant melanoma (2001) (0)

This paper list is powered by the following services:

Other Resources About Jeffrey Trent

en.wikipedia.org

What Schools Are Affiliated With Jeffrey Trent?

Jeffrey Trent is affiliated with the following schools: